Condition: Epileptic Encephalopathy · SCN2A Encephalopathy · Sponsor: Praxis Precision Medicines
A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants with Early Onset SCN2A Developmental and Epileptic Encephalopathy
This description comes directly from the study's public registry record.
Head of Pharmacovigilance · 617-300-8460 · clinicaltrials@praxismedicines.com
Always discuss trial participation with your own doctor first.
| Praxis Research Site | San Diego, California, United States | Recruiting |
| Praxis Research Site | Aurora, Colorado, United States | Recruiting |
| Praxis Research Site | Chicago, Illinois, United States | Recruiting |
| Praxis Research Site | Cincinnati, Ohio, United States | Recruiting |
| Praxis Research Site | Philadelphia, Pennsylvania, United States | Recruiting |
| Praxis Research Site | Memphis, Tennessee, United States | Recruiting |
| Praxis Research Site | Porto Alegre, Brazil | Withdrawn |
| Praxis Research Site | São Paulo, Brazil | Withdrawn |
| Praxis Research Site | Bonn, Bonn, Germany | Recruiting |
| Praxis Research Site | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07019922